UniProt ID | IPO11_HUMAN | |
---|---|---|
UniProt AC | Q9UI26 | |
Protein Name | Importin-11 | |
Gene Name | IPO11 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 975 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). Mediates the nuclear import of UBE2E3, and of RPL12 (By similarity).. | |
Protein Sequence | MDLNSASTVVLQVLTQATSQDTAVLKPAEEQLKQWETQPGFYSVLLNIFTNHTLDINVRWLAVLYFKHGIDRYWRRVAPHALSEEEKTTLRAGLITNFNEPINQIATQIAVLIAKVARLDCPRQWPELIPTLIESVKVQDDLRQHRALLTFYHVTKTLASKRLAADRKLFYDLASGIYNFACSLWNHHTDTFLQEVSSGNEAAILSSLERTLLSLKVLRKLTVNGFVEPHKNMEVMGFLHGIFERLKQFLECSRSIGTDNVCRDRLEKTIILFTKVLLDFLDQHPFSFTPLIQRSLEFSVSYVFTEVGEGVTFERFIVQCMNLIKMIVKNYAYKPSKNFEDSSPETLEAHKIKMAFFTYPTLTEICRRLVSHYFLLTEEELTMWEEDPEGFTVEETGGDSWKYSLRPCTEVLFIDIFHEYNQTLTPVLLEMMQTLQGPTNVEDMNALLIKDAVYNAVGLAAYELFDSVDFDQWFKNQLLPELQVIHNRYKPLRRRVIWLIGQWISVKFKSDLRPMLYEAICNLLQDQDLVVRIETATTLKLTVDDFEFRTDQFLPYLETMFTLLFQLLQQVTECDTKMHVLHVLSCVIERVNMQIRPYVGCLVQYLPLLWKQSEEHNMLRCAILTTLIHLVQGLGADSKNLYPFLLPVIQLSTDVSQPPHVYLLEDGLELWLVTLENSPCITPELLRIFQNMSPLLELSSENLRTCFKIINGYIFLSSTEFLQTYAVGLCQSFCELLKEITTEGQVQVLKVVENALKVNPILGPQMFQPILPYVFKGIIEGERYPVVMSTYLGVMGRVLLQNTSFFSSLLNEMAHKFNQEMDQLLGNMIEMWVDRMDNITQPERRKLSALALLSLLPSDNSVIQDKFCGIINISVEGLHDVMTEDPETGTYKDCMLMSHLEEPKVTEDEEPPTEQDKRKKMLALKDPVHTVSLQQFIYEKLKAQQEMLGEQGFQSLMETVDTEIVTQLQEFLQGF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLNSAST -------CCHHHHHH | 13.76 | 19413330 | |
5 | Phosphorylation | ---MDLNSASTVVLQ ---CCHHHHHHHHHH | 30.78 | 30576142 | |
7 | Phosphorylation | -MDLNSASTVVLQVL -CCHHHHHHHHHHHH | 22.89 | 30576142 | |
8 | Phosphorylation | MDLNSASTVVLQVLT CCHHHHHHHHHHHHH | 17.85 | 24043423 | |
10 (in isoform 2) | Phosphorylation | - | 2.91 | 24043423 | |
13 (in isoform 2) | Phosphorylation | - | 5.66 | 24043423 | |
14 (in isoform 2) | Phosphorylation | - | 1.57 | 24043423 | |
15 | Phosphorylation | TVVLQVLTQATSQDT HHHHHHHHHCCCCCC | 19.80 | 24043423 | |
17 (in isoform 2) | Phosphorylation | - | 12.18 | 24043423 | |
18 | Phosphorylation | LQVLTQATSQDTAVL HHHHHHCCCCCCEEC | 19.66 | 30576142 | |
19 | Phosphorylation | QVLTQATSQDTAVLK HHHHHCCCCCCEECC | 29.13 | 24043423 | |
20 (in isoform 2) | Phosphorylation | - | 47.95 | 24043423 | |
22 | Phosphorylation | TQATSQDTAVLKPAE HHCCCCCCEECCHHH | 15.84 | 24043423 | |
83 | Phosphorylation | RVAPHALSEEEKTTL HHCHHCCCHHHHHHH | 43.69 | 20068231 | |
87 | Ubiquitination | HALSEEEKTTLRAGL HCCCHHHHHHHHHHH | 50.52 | 24816145 | |
127 | Ubiquitination | DCPRQWPELIPTLIE CCCCCCCHHHHHHHH | 57.27 | 24816145 | |
161 | Ubiquitination | VTKTLASKRLAADRK HHHHHHHHHHHHCHH | 45.91 | 27667366 | |
201 | Ubiquitination | QEVSSGNEAAILSSL HHHHCCCHHHHHHHH | 42.90 | 27667366 | |
206 | Phosphorylation | GNEAAILSSLERTLL CCHHHHHHHHHHHHH | 27.11 | 24719451 | |
214 | Phosphorylation | SLERTLLSLKVLRKL HHHHHHHHHHHHHHH | 29.29 | 24719451 | |
216 | Ubiquitination | ERTLLSLKVLRKLTV HHHHHHHHHHHHHCC | 35.53 | 23000965 | |
220 | Ubiquitination | LSLKVLRKLTVNGFV HHHHHHHHHCCCCEE | 44.33 | 23000965 | |
247 | Ubiquitination | HGIFERLKQFLECSR HHHHHHHHHHHHHHH | 45.27 | 24816145 | |
256 | Ubiquitination | FLECSRSIGTDNVCR HHHHHHHHCCCCHHH | 7.18 | 21890473 | |
256 | Ubiquitination | FLECSRSIGTDNVCR HHHHHHHHCCCCHHH | 7.18 | 21890473 | |
256 (in isoform 2) | Ubiquitination | - | 7.18 | - | |
260 | Ubiquitination | SRSIGTDNVCRDRLE HHHHCCCCHHHHHHH | 34.33 | 23000965 | |
287 | Ubiquitination | FLDQHPFSFTPLIQR HHHHCCCCCHHHHHH | 32.44 | 24816145 | |
305 | Phosphorylation | FSVSYVFTEVGEGVT EEEEEEEEECCCCCC | 21.51 | 19053533 | |
312 | Phosphorylation | TEVGEGVTFERFIVQ EECCCCCCHHHHHHH | 30.54 | 19053533 | |
334 | Ubiquitination | IVKNYAYKPSKNFED HHHHCCCCCCCCCCC | 34.34 | 27667366 | |
337 | Ubiquitination | NYAYKPSKNFEDSSP HCCCCCCCCCCCCCH | 74.34 | 29967540 | |
342 | Phosphorylation | PSKNFEDSSPETLEA CCCCCCCCCHHHHHH | 40.36 | 29255136 | |
343 | Phosphorylation | SKNFEDSSPETLEAH CCCCCCCCHHHHHHH | 38.79 | 29255136 | |
346 | Phosphorylation | FEDSSPETLEAHKIK CCCCCHHHHHHHHCE | 33.03 | 23663014 | |
351 | Acetylation | PETLEAHKIKMAFFT HHHHHHHHCEEHHHC | 51.58 | 25953088 | |
351 | Ubiquitination | PETLEAHKIKMAFFT HHHHHHHHCEEHHHC | 51.58 | 29967540 | |
361 | Phosphorylation | MAFFTYPTLTEICRR EHHHCCHHHHHHHHH | 35.58 | - | |
374 | Ubiquitination | RRLVSHYFLLTEEEL HHHHHHHHCCCHHHH | 3.64 | 27667366 | |
377 | Ubiquitination | VSHYFLLTEEELTMW HHHHHCCCHHHHHCC | 43.42 | 29967540 | |
383 | Phosphorylation | LTEEELTMWEEDPEG CCHHHHHCCCCCCCC | 7.10 | 27251275 | |
391 | Ubiquitination | WEEDPEGFTVEETGG CCCCCCCCEEEECCC | 7.06 | 29967540 | |
404 | Phosphorylation | GGDSWKYSLRPCTEV CCCCCEEECCCCCEE | 17.74 | 24719451 | |
540 | Ubiquitination | IETATTLKLTVDDFE EEECCEEEEEECCCC | 39.77 | 29901268 | |
580 | Ubiquitination | ECDTKMHVLHVLSCV HCCCHHHHHHHHHHH | 3.37 | 29901268 | |
784 | Phosphorylation | GIIEGERYPVVMSTY HHHCCCCCCCHHHHH | 8.97 | 20068231 | |
846 | Ubiquitination | ITQPERRKLSALALL CCCHHHHHHHHHHHH | 53.68 | - | |
854 | Phosphorylation | LSALALLSLLPSDNS HHHHHHHHCCCCCCH | 28.80 | 20860994 | |
858 | Phosphorylation | ALLSLLPSDNSVIQD HHHHCCCCCCHHHCC | 49.77 | 20860994 | |
861 | Phosphorylation | SLLPSDNSVIQDKFC HCCCCCCHHHCCCCC | 26.11 | 20860994 | |
898 | Phosphorylation | YKDCMLMSHLEEPKV HHHCHHHHCCCCCCC | 22.43 | 28555341 | |
917 | Ubiquitination | EPPTEQDKRKKMLAL CCCCHHHHHHHHHHH | 66.85 | 21890473 | |
940 | Ubiquitination | LQQFIYEKLKAQQEM HHHHHHHHHHHHHHH | 38.01 | 29967540 | |
980 | Ubiquitination | QGF------------ CCC------------ | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IPO11_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IPO11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IPO11_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PLCD4_HUMAN | PLCD4 | physical | 16189514 | |
RL12_HUMAN | RPL12 | physical | 11809816 | |
RAN_HUMAN | RAN | physical | 11032817 | |
UB2E1_HUMAN | UBE2E1 | physical | 11032817 | |
UB2E3_HUMAN | UBE2E3 | physical | 15545318 | |
UB2E1_HUMAN | UBE2E1 | physical | 15545318 | |
UB2E2_HUMAN | UBE2E2 | physical | 15545318 | |
NXF1_HUMAN | NXF1 | physical | 21965294 | |
SH3G2_HUMAN | SH3GL2 | physical | 22939629 | |
SYAC_HUMAN | AARS | physical | 22863883 | |
CYBP_HUMAN | CACYBP | physical | 22863883 | |
NC2B_HUMAN | DR1 | physical | 22863883 | |
IF4A3_HUMAN | EIF4A3 | physical | 22863883 | |
HNRPD_HUMAN | HNRNPD | physical | 22863883 | |
HNRH1_HUMAN | HNRNPH1 | physical | 22863883 | |
PDLI5_HUMAN | PDLIM5 | physical | 22863883 | |
KPYM_HUMAN | PKM | physical | 22863883 | |
PLIN3_HUMAN | PLIN3 | physical | 22863883 | |
PRDX2_HUMAN | PRDX2 | physical | 22863883 | |
RAGP1_HUMAN | RANGAP1 | physical | 22863883 | |
SRP09_HUMAN | SRP9 | physical | 22863883 | |
TPRKB_HUMAN | TPRKB | physical | 22863883 | |
CA094_HUMAN | C1orf94 | physical | 25416956 | |
STOM_HUMAN | STOM | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |